
vTv Therapeutics Inc. (NASDAQ:VTVT) initiated its Phase 2 clinical trial for evaluating azeliragon in patients with mild Alzheimer’s disease and Type 2 Diabetes. vTv Therapeutics …
vTv Therapeutics Inc. (NASDAQ:VTVT) initiated its Phase 2 clinical trial for evaluating azeliragon in patients with mild Alzheimer’s disease and Type 2 Diabetes. vTv Therapeutics …